CHICAGO For those of you who think biotechnology is just some passing fad (particularly in the Midwest), get ready because biotech is big business and its here to stay. More than that, its a global business.
Perhaps the group that best tracks the growth of biotech around the globe is the audit firm Ernst & ......
Full article >>>
s three public equity markets where a biotech company could list: the Nasdaq National Market, the Nasdaq Small Cap Market and the Amex. In Europe, there is the alternative market to the London Stock Exchange and newer markets in Switzerland, France, etc. The European Nasdaq has gone out of business and the German Neuer Market has likewise stopped functioning.
Though smaller country marke......Full article >>>
The opening of biotech bilateral regional corridors between different parts of the world has already commenced with the east and west coasts of the U.S. some 10 to 15 years ago (particularly between the U.K. and Europe). During this period, the Midwest was ignored as a biotech wasteland. The recent surge in biotech activities (including the commercialization of university research) in t......Full article >>>
iversity of Chicagos Gleacher Center called Breakfast with German Life Science, which will feature German Big Pharma, German biotech, German VCs and the German government.
After the U.S. and Canada, Germany has the third-largest number of biotech companies (its approaching almost 400).
Recently, the Chicago Tribune featured an article about a German life science start-up ca......Full article >>>
Source:wistechnology.com By Michael Rosen 09/15/03Related biology technology :1
. Impact of e-medical records will be felt at home2
. Impact of research park firms pegged at $680M3
. The Industry Impact of Two Big Pharmas Mating4
. Symposium To Explore Information Technologys Impact on Improving Quality, Cost Effectiveness of Healthcare5
. Biotech officials praise focus of new venture fund6
. Biotech executive books a career flight thats closer to home7
. Gala Biotech among companies sold for $3.3 billion8
. Biotech with Madison ties raises $21M in capital9
. Biotech firm uses live heart tissue in drug screens10
. Biotech talent drew venture-funded firm to Madison11
. Biotech firm has strokes, Alzheimers in its sights